ALLISON RISLEY: Open Payments
NPI 1215403100 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 25 payments from 6 companies in 2025. Trend: 2023 $125 · 2024 $572 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $263 |
| GENZYME CORPORATION | 7 | $158 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
| Amgen Inc. | 1 | $35 |
| Incyte Corporation | 1 | $27 |
| MERZ NORTH AMERICA, INC. | 1 | $27 |
Products named: COSENTYX, DUPIXENT, OTEZLA, OPZELURA.
Industry payments across WA — which companies pay providers there.
